Evaxion A/S

NASDAQ: EVAX
Share price (8/15/25): $2.88
Market cap (8/15/25): $18.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers – amended

Ownership Filter

Armistice Capital, LLC

Armistice Capital, LLC

Merck & Company Inc.

Armistice Capital, LLC

Merck & Company Inc.

News Filter

Announces Business Update and Second Quarter 2025 Financial Results

Management’s Discussion and Analysis of Financial Condition and Results of Operations

To Announce Business Update and Second Quarter 2025 Financial Results on August 14, 2025

To Present Two-Year Clinical Efficacy Data From Phase 2 Trial With AI-designed Personalized Cancer Vaccine EVX-01 at the ESMO Congress 2025

Material disclosure

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC